SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-053928
Filing Date
2020-11-13
Accepted
2020-11-13 17:24:18
Documents
53
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q life-10q_20200930.htm 10-Q 2276031
2 EX-5.1 life-ex51_184.htm EX-5.1 17845
3 EX-10.1 life-ex101_245.htm EX-10.1 19927
4 EX-31.1 life-ex311_8.htm EX-31.1 9629
5 EX-31.2 life-ex312_6.htm EX-31.2 9125
6 EX-32.1 life-ex321_7.htm EX-32.1 5509
7 EX-32.2 life-ex322_9.htm EX-32.2 5498
8 GRAPHIC gmv3rgly4cri000001.jpg GRAPHIC 28720
  Complete submission text file 0001564590-20-053928.txt   6629717

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT life-20200930.xml EX-101.INS 1280124
10 XBRL TAXONOMY EXTENSION SCHEMA life-20200930.xsd EX-101.SCH 45041
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE life-20200930_cal.xml EX-101.CAL 43136
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE life-20200930_def.xml EX-101.DEF 176742
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE life-20200930_lab.xml EX-101.LAB 360352
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE life-20200930_pre.xml EX-101.PRE 276198
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37378 | Film No.: 201312672
SIC: 2836 Biological Products, (No Diagnostic Substances)